1. In vitro activity of antiseptic solutions against Madurella mycetomatis: implications for eumycetoma management. (1st June 2015) Authors: Eadie, K.; Fahal, A.; van de Sande, W.W.J. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In vitro activity of antiseptic solutions against Madurella mycetomatis: implications for eumycetoma management. (29th April 2015) Authors: Eadie, K.; Fahal, A.; van de Sande, W.W.J. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In vitro activity of antiseptic solutions against Madurella mycetomatis: implications for eumycetoma management. (29th April 2015) Authors: Eadie, K.; Fahal, A.; van de Sande, W.W.J. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1657 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. MycetOS – An open research model discover new drugs to treat one of the most neglected disease – Mycetoma. (December 2020) Authors: Lim, W.; Eadie, K.; Konings, M.; van de Sande, W. Journal: International journal of infectious diseases Issue: Volume 101(2020)Supplement 1 Page Start: 388 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Olorofim is potent against Madurella mycetomatis – the most common causative agent of Eumycetoma. (December 2020) Authors: Lim, W.; Eadie, K.; Rijnders, B.; Fahal, A.; Oliver, J.; Birch, M.; van de Sande, W. Journal: International journal of infectious diseases Issue: Volume 101(2020)Supplement 1 Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗